Perth biotech PYC Therapeutics will go to market seeking $653 million to advance four of its treatments through early trial stages and towards their first transaction.The Nedlands-based ASX-list
PYC Therapeutics has announced that Peter Coleman has been appointed non-executive chair, effective from the end of its annual general meeting on November 18.
Perth-based PYC Therapeutics is battling to complete its $146 million capital raising after a large shortfall from retail investors and a “liquidity” issue by one of its underwriters.
Nedlands-based biotech company PYC Therapeutics is rattling the tin for up to $146 million to fund the progression of four novel drug candidates.Company chair and largest shareholder Alan Tribe
Business News has significantly overhauled the BN30 index, a proxy for the WA economy, with seven new additions, prompted by the exit of takeover targets MMA Offshore, APM and Decmil.
Perth biotech company PYC Therapeutics has hit a major milestone in the development of a first-in-class drug to treat a rare eye disease, recently receiving orphan drug designation from the US FDA.
PYC Therapeutics is rattling the tin for up to $74.6 million to fund the progress of its medical drug trials, including for blinding eye and polycystic kidney diseases.
Perth biotechnology company PYC Therapeutics will collaborate with Google to develop and host an artificial intelligence platform for precision medicines.
Property developer Exal Group has bought a 31,100 square metre lot from a Chinese real estate group, as it progresses its plans for its project worth more than $500 million at the site.
GenusPlus Group managing director David Riches was named First Amongst Equals at the 2022 40under40 Awards, ahead of a diverse cohort of Western Australia's young business leaders.
Four companies including VeinTech and Vision Pharma have been selected as finalists in the Great for the State category at the Innovator of the Year Awards.
Today's board moves wrap includes Cliff Lawrenson, David Netherway, Emmanuel Correia, Sahm Nasseri, Kaggen Ausma, Andrew Barclay, Raymond Parry, and Emma Stein.
Today's board moves wrap includes Jason Bontempo, Alex McCulloch, Rodney Johns, Geoff Greenhill, Warwick Davies, John Klepec, Patrick Burke, David Frances, David Minchin, and Douglas Huey.
Our weekly appointments wrap includes Sue Fletcher, Henry van der Westhuizen, Alec O'Connell, Louise-Marlena Tarrier, Danielle Norrish and Georgia Cameron.
Our board moves wrap includes Richard Monti, Kristie Young, Bryn Hardcastle, Rohan Hockings, Douglas Huey, Dale Schultz, Paul Summers, and Louie Simens.
The ASX has launched a technology index with 46 constituent companies and while several, such as Nearmap and ResApp Health, have a WA connection, none are based in Perth.
Biotech company Phylogica announced it had increased its shareholding in Vision Pharma to 90 per cent, following a $15 million investment using funds it had raised through a recent rights issue.
